Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Privia Health Group Inc shares valued at $341,311 were sold by Morris Matthew Shawn on Dec 12 ’25. At $25.01 per share, Morris Matthew Shawn sold 13,647 shares. The insider’s holdings dropped to 68,188 shares worth approximately $1.58 million following the completion of this transaction.
Also, Mountcastle David sold 23,887 shares, netting a total of over 597,892 in proceeds. Following the sale of shares at $25.03 each, the insider now holds 172,909 shares.
Before that, Matthew Shawn Morris had added 833,340 shares to its account. In a trade valued at $20,758,499, the Director bought Privia Health Group Inc shares for $24.91 each.
As published in their initiating research note from BMO Capital Markets on November 13, 2025, Privia Health Group Inc [PRVA] has been an Outperform and the price target has been revised to $30. Analysts at Needham started covering the stock with ‘”a Buy”‘ outlook in a report released in early January. As of December 16, 2024, Macquarie has initiated its “an Outperform” rating for PRVA. Earlier on October 11, 2024, KeyBanc Capital Markets initiated its rating. Their recommendation was “an Overweight” for PRVA stock.
Analyzing PRVA Stock Performance
On last trading session, Privia Health Group Inc [NASDAQ: PRVA] plunged -4.34% to $23.15. The stock’s lowest price that day was $22.89, but it reached a high of $24.555 in the same session. During the last five days, there has been a drop of approximately -2.36%. Over the course of the year, Privia Health Group Inc shares have jumped approximately 14.32%. Shares of the company reached a 52-week high of $24.60 on 01/07/26 and a 52-week low of $22.89 on 01/08/26.
Support And Resistance Levels for Privia Health Group Inc (PRVA)
According to the 24-hour chart, there is a support level at 22.51, which, if violated, would cause prices to drop to 21.87. In the upper region, resistance lies at 24.17. The next price resistance is at 25.20. RSI (Relative Strength Index) is 41.13 on the 14-day chart, showing neutral technical sentiment.
Is Privia Health Group Inc subject to short interest?
Stocks of Privia Health Group Inc saw a sharp steep in short interest on 2025-12-15 dropping by -0.22 million shares to 3.01 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 3.23 million shares. A decline of -7.19% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.49 of the overall float, the days-to-cover ratio (short ratio) decline to 4.49.
Which companies own the most shares of Privia Health Group Inc (PRVA)?
In terms of Privia Health Group Inc share price expectations, FactSet research, analysts set an average price target of 30.5 in the next 12 months, up nearly 26.03% from the previous closing price of $24.2. Analysts anticipate Privia Health Group Inc stock to reach 34 by 2026, with the lowest price target being 22. In spite of this, 10 analysts ranked Privia Health Group Inc stock as Buy at the end of 2026. On May 30, 2024, Robert W. Baird assigned a price target of “an Outperform” to the stock and initiated coverage with a $23.
